A phase I study of OX-382
Phase of Trial: Phase I
Latest Information Update: 25 Jan 2018
At a glance
- Drugs OX 382 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- 25 Jan 2018 According to an Orexo media release, trial results expected in Q2, 2018.
- 25 Jan 2018 Status changed from planning to recruiting, according to an Orexo media release.
- 19 Oct 2017 According to an Orexo media release, this trial is scheduled to start in the first quarter of 2018.